Doxofylline
CAS No. 69975-86-6
Doxofylline ( Doxofylline; Ansimar; ABC-12-3; ABC-1213; ABC 1213; ALT 07; DO 309 )
Catalog No. M15684 CAS No. 69975-86-6
Doxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 30 | In Stock |
|
100MG | 43 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDoxofylline
-
NoteResearch use only, not for human use.
-
Brief DescriptionDoxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.
-
DescriptionDoxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.
-
SynonymsDoxofylline; Ansimar; ABC-12-3; ABC-1213; ABC 1213; ALT 07; DO 309
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number69975-86-6
-
Formula Weight266.26
-
Molecular FormulaC11H14N4O4
-
Purity>98%(HPLC)
-
SolubilityEthanol: 2 mg/mL (7.51 mM); Water: 24 mg/mL (90.14 mM); DMSO: 53 mg/mL (199.06 mM)
-
SMILESO=C(N1C)N(C)C2=C(N(CC3OCCO3)C=N2)C1=O
-
Chemical Name7-((1,3-dioxolan-2-yl)methyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shukla D, et al. Expert Opin PharmacOthers, 2009, 10(14), 2343-2356.
molnova catalog
related products
-
THPP-1
THPP-1 is a potent and orally bioavailable inhibitor of PDE10A(Ki of 1 nM and 1.3 nM for human and rat PDE10A, respectively).
-
Carbazeran
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
Apremilast
Apremilast (CC-10004) is a potent, orally active PDE4 inhibitor with IC50 of 74 nM, inhibits TNF-α production in LPS-stimulated hPBMCs with IC50 of 77 nM.